DPYD Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation

MLA

Theodore J. Wigle, et al. “DPYD Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation.” Current Oncology, vol. 30, no. 1, Jan. 2023, pp. 663–72. EBSCOhost, https://doi.org/10.3390/curroncol30010051.

APA

Theodore J. Wigle, Samantha Medwid, Cameron Ross, Ute I. Schwarz, & Richard B. Kim. (2023). DPYD Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation. Current Oncology, 30(1), 663–672. https://doi.org/10.3390/curroncol30010051

Chicago

Theodore J. Wigle, Samantha Medwid, Cameron Ross, Ute I. Schwarz, and Richard B. Kim. 2023. “DPYD Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation.” Current Oncology 30 (1): 663–72. doi:10.3390/curroncol30010051.